论文部分内容阅读
目的探析卡培他滨治疗老年晚期胃肿瘤患者的临床效果。方法 94例老年晚期胃肿瘤患者,随机分为观察组和对照组,每组47例。对照组给予紫杉醇治疗,观察组运用卡培他滨口服治疗,对两组的近期疗效以及不良反应发生率进行对比。结果与对照组比较,观察组的近期疗效明显较高,差异有统计学意义(P<0.05);两组在疾病进展时间和不良反应发生率方面比较差异有统计学意义(P<0.05)。结论临床上运用卡培他滨对老年晚期胃肿瘤患者进行治疗,不仅可以获得较好的疗效,还能使患者的生存时间延长,值得临床推广。
Objective To investigate the clinical effect of capecitabine in the treatment of elderly patients with advanced gastric cancer. Methods 94 cases of elderly patients with advanced gastric cancer were randomly divided into observation group and control group, 47 cases in each group. The control group was treated with paclitaxel. The observation group was treated with capecitabine orally, and the short-term curative effect and incidence of adverse reactions in the two groups were compared. Results Compared with the control group, the short-term efficacy of the observation group was significantly higher (P <0.05). There was significant difference between the two groups in disease progression time and incidence of adverse reactions (P <0.05). Conclusion The clinical use of capecitabine in the treatment of elderly patients with advanced gastric cancer can not only achieve better curative effect, but also prolong the survival time of patients and deserve clinical promotion.